hip osteoarthritis. Osteoarthritis of hip
Conditions
Interventions
Intervention 1: Intervention group: platelet rich plasma , hip intraarticular injection, 4 to 6 milliliter, 2 times, 2 weeks interval. Intervention 2: Intervention group: Hyaluronic acid (molecular we
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patients with hip osteoarthritis based on American College of Rheumatology criteria at the age of 70-40 years and with the duration of symptoms more than three months that are recognized by hip x-ray (Grade 2 and 3) at the age of 70-40 years duration of symptoms more than three months Grade 2 and 3 recognized by hip x-ray
Exclusion criteria
Exclusion criteria: Systemic diseases such as diabetes mellitus,collagen vascular disorders or immune deficiency History of malignancy Hip infection or active wound History of NSAIDs usage within 2 days before injection Patients who were under anticoagulant or antiplatelet treatments within 10 days before injection Hemoglobin < 12 and plt < 150000 History of severe hip trauma Pregnancy and breastfeeding Allergy to protein of egg , feather or hypersensitivity to hyaluronate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hip pain. Timepoint: before intervention,2 months & 6months after intervention. Method of measurement: changes of WOMAC and VAS and LEQUESNE questionnaires scores.;Joint stiffness. Timepoint: before intervention,2 months & 6 months after intervention. Method of measurement: change of WOMAC questionnaire scores.;Function. Timepoint: before intervention,2 months & 6 months after intervention. Method of measurement: change of WOMAC questionnaire scores.;Activity of daily living. Timepoint: before intervention,2 months & 6 months after intervention. Method of measurement: change of LEQUESNE questionnaire scores. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactParya Peydayesh
Shahid Modarres Hospital
Outcome results
None listed